(Q51135653)

30 March 2018

meta-analysis

0 references

title

Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. (English)

1 reference

30 March 2018

1 reference

2

1 reference

30 March 2018

author name string

Young Ho Lee

series ordinal

1

1 reference

30 March 2018

publication date

16 February 2017

1 reference

30 March 2018

International Journal of Rheumatic Diseases

published in

1 reference

30 March 2018

Rheumatoid arthritis. Pathophysiology and implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Biochemistry of adipose tissue: an endocrine organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Visfatin: a potential therapeutic target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

Plasma Adiponectin in Patients with Active, Early, and Chronic Rheumatoid Arthritis Who Are Steroid- and Disease-Modifying Antirheumatic Drug-Naive Compared with Patients with Osteoarthritis and Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13038

21 January 2018

Identifiers

DOI

10.1111/1756-185X.13038

1 reference

30 March 2018

PubMed ID

28205390

1 reference

30 March 2018